Systematic evaluation of self-adjuvanting lipopeptide nano-vaccine platforms for the induction of potent CD8⁺ T-cell responses
Apte, Simon H., Stephenson, Rachel J., Simerska, Pavla, Groves, Penny L., Aljohani, Salwa, Eskandari, Sharareh, Toth, Istvan, and Doolan, Denise L. (2016) Systematic evaluation of self-adjuvanting lipopeptide nano-vaccine platforms for the induction of potent CD8⁺ T-cell responses. Nanomedicine, 11 (2). pp. 137-152.
PDF (Published Version)
- Published Version
Restricted to Repository staff only |
Abstract
Aim: Systematically evaluate lipid core peptide vaccine delivery platforms to identify core features promoting strong CD8⁺ T-cell responses.
Materials & methods: Three different self-adjuvanting lipid core peptide nanovaccines each comprising four copies of the dominant ovalbumin CD8⁺ T-cell epitope and varying in the utilization of a polylysine or glucose core with 2-amino-hexadecanoic acid (C16) or 2-amino-dodecanoic acid (C12) lipids were synthesized. Vaccines were tested for ability to induce CD8⁺ T-cell responses and inhibit tumor growth in vivo.
Results: The construct utilizing C12 lipids and polylysine core induced very robust effector T cells shown to have in vivo effector capability as demonstrated by in vivo cytotoxicity and ability to inhibit tumor growth as well as modulation of dendritic cell activation.
Conclusion: The C12 polylysine platform was an effective configuration for induction of potent CD8⁺ T-cell responses.
Item ID: | 46649 |
---|---|
Item Type: | Article (Research - C1) |
ISSN: | 1748-6963 |
Keywords: | CD8+ T cells; dendritic cells; lipid core peptide; nanovaccine; self-adjuvant; vaccine |
Funders: | National Health and Medical Research Council (NHMRC), Australian Research Council (ARC), University of Queensland (UQ) |
Projects and Grants: | NHMRC APP1037304, NHMRC APP1026488, NHMRC 1023636, ARC Discovery Project Grant DP1092829, ARC DP110100212, UQ 606431 |
Date Deposited: | 15 Dec 2016 02:45 |
FoR Codes: | 42 HEALTH SCIENCES > 4206 Public health > 420699 Public health not elsewhere classified @ 50% 32 BIOMEDICAL AND CLINICAL SCIENCES > 3204 Immunology > 320404 Cellular immunology @ 25% 32 BIOMEDICAL AND CLINICAL SCIENCES > 3204 Immunology > 320405 Humoural immunology and immunochemistry @ 25% |
SEO Codes: | 92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920109 Infectious Diseases @ 100% |
Downloads: |
Total: 1 |
More Statistics |